Flexible solid oral dosage forms of medicines are ideal for children.
理想的儿童药物为灵活的固体口服剂型。
Objective To introduce FDA's biowaiver policy for IR solid oral dosage forms.
目的介绍FDA关于普通口服固体制剂生物等效豁免的相关政策。
Promoting the need for flexible solid oral dosage forms and fixed-dose combinations for children is required.
必须促进对灵活的固体口服剂型和儿童固定剂量复合制剂的需要。
应用推荐